KDL Biotech - News
NSE: KOPDRUGS | BSE: 532291
₹2.14
As on 16-Mar-2015IST
Market cap
₹5 Cr
Revenue (TTM)
₹26 Cr
P/E Ratio
--
P/B Ratio
-0.1
Div. Yield
0 %
Annual Reports
Announcements
View AnnouncementsExtension of Time for Holding A G M
25-Sep-2013Financial Results for March 31, 2013 (Audited)
31-May-2013Resignation of Director & Company Secretary
04-May-2013No News & Announcements are available.